gc012f
gracell biotechnologies
['gc012f ']
gracell #biotechnologies presents updated clinical data for bcma/cd19 dual-targeting fastcar gc012f in rrmm at eha2022 congress, highlighting 100% mrd negativity rate in all treated patients #stocksmarket #pressrelease
Join us at https://t.co/9QZSYoqhvl - Stock Market News and Press Releases. #StockMarket - As an affiliate, we earn from qualifying purchases.